banner

THE FINANCIAL EXPRESS

  • email
  • twitter
  • linkedin
  • facebook
Stock Corner: ‘Buy' on Aurobindo Pharma, Unit 4 Issues Will Need Robust Efforts
The USFDA inspected Aurobindo Pharma’s (ARBP’s) Unit 4 from 4th-13th Nov’19 and issued form 483 with 14 observations.Observations are largely...

Gene-Editing Tool CRISPR Repurposed to Develop Better Antibiotics
Resistance to current antibiotics by disease-causing pathogens is a growing problem, one estimated to endanger millions of lives and cost over...